FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series B / Health care startups that raised Series B in the United States

Health care startups that raised Series B in the United States

Updated 16 Nov 2026

Reset
Health care startups that raised Series B in the United States
One-time CSV
  • 1,286 funded companies, 1,163 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-b~united-states.csv1,286 rows × 18 columns
CompanyCityLast roundAmountDate
Prolific MachinesEmeryvilleSeries B$50.0M2026-10-14
Multiply LabsSan FranciscoSeries B$75.0M2026-10-06
Tiny HealthAustinSeries B$33.0M2026-09-29
UltraSightCambridgeSeries B$24.0M2026-09-23
EvvyNew YorkSeries B$40.0M2026-09-15
VibronixWest LafayetteSeries B$14.9M2026-09-14
Moonwalk BiosciencesSouth San FranciscoSeries B$70.0M2026-09-08
Superluminal MedicinesBostonSeries B$65.5M2026-09-03

8 rows of the CSV in 5 of its 18 columns.

1,286
Startups
$73.8B
Total raised
134
Funded in the last 12 months
$7.6B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 1,286
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Prolific Machines Prolific Machines develops light-controlled gene expression systems for producing therapeutics. Artificial intelligence Emeryville Series B $50.0M 2026-10-14 $147.0M SOSV, Mayfield Fund, SOSV SF & NY (Fka IndieBio) +2 51 to 100 2020
Multiply Labs Multiply Labs builds robotic systems that automate biologics manufacturing. Artificial intelligence San Francisco Series B $75.0M 2026-10-06 $97.7M Y Combinator, Founders Fund, Garage Capital +2 11 to 50 2016
Tiny Health Tiny Health offers at-home microbiome testing and health insights for babies, children, adults, and pregnant people. Biotech Austin Series B $33.0M 2026-09-29 $46.0M TheVentureCity, Next Coast Ventures, Spero Ventures +2 11 to 50 2020
UltraSight UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. Health care Cambridge Series B $24.0M 2026-09-23 $39.0M Yozma Group 11 to 50 2018
Evvy Evvy offers an AI-driven precision medicine platform focused on women's health. Artificial intelligence New York Series B $40.0M 2026-09-15 $59.0M General Catalyst, BoxGroup, Left Lane Capital +2 11 to 50 2021
Vibronix Vibronix develops optical and acoustic imaging and sensing technology for surgical guidance and diagnosis. Artificial intelligence West Lafayette Series B $14.9M 2026-09-14 $31.0M National Science Foundation, Frees Fund, Founder H Fund +1 11 to 50 2013
Moonwalk Biosciences Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. Artificial intelligence South San Francisco Series B $70.0M 2026-09-08 $127.0M Google Ventures, Khosla Ventures, ARCH Venture Partners +2 11 to 50 2022
Superluminal Medicines Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. Artificial intelligence Boston Series B $65.5M 2026-09-03 $223.5M Insight Partners, RA Capital Management, NVentures 11 to 50 2022
David David makes high-protein, low-calorie foods that support muscle growth and fat reduction. Health care New York Series B $250.0M 2026-09-02 $335.0M Valor Siren Ventures 101 to 250 2023
N-Power Medicine N-Power Medicine is a biotechnology company that uses AI to offer clinical research and drug development services. Artificial intelligence Redwood City Series B $32.0M 2026-09-01 $104.0M Merck Global Health Innovation Fund 101 to 250 2021
Faro AI Faro AI develops software that automates clinical workflows and assists with clinical trial design. Artificial intelligence San Diego Series B $37.3M 2026-08-26 $72.3M General Catalyst, Polaris Partners, Zetta Venture Partners +2 11 to 50 2019
Arintra Arintra provides AI software that helps enterprises detect and prevent revenue loss. Artificial intelligence Austin Series B $25.0M 2026-08-21 $46.4M Y Combinator, Surge, TEN13 11 to 50 2020
Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Cambridge Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
InduPro InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. Biotech Seattle Series B $77.0M 2026-08-12 $162.0M Euclidean Capital, The Column Group, Vida Ventures +1 51 to 100 2022
Flagler Health Flagler Health recommends treatment strategies to physicians using patient data and artificial intelligence. Artificial intelligence New York Series B $50.0M 2026-08-11 $58.5M MassChallenge 11 to 50 2023
Aureka Biotechnologies Aureka Biotechnologies uses AI to discover protein therapeutics and antibody treatments. Artificial intelligence Laguna Hills Series B $100.0M 2026-08-10 $168.4M K2VC, NRL Capital 11 to 50 2023
Theradaptive Theradaptive develops protein therapeutics for spine, orthopedics, and targeted immuno-oncology. Biotech Frederick Series B $36.2M 2026-08-04 $71.0M Maryland Stem Cell Research Fund (MSCRF) 11 to 50 2016
Wellinks (formerly Convexity Scientific) Wellinks develops wearable health technology to improve clinical outcomes for patients. Health care New Haven Series B $10.0M 2026-08-04 $52.6M Connecticut Innovations, Stonehenge Capital, 5Y Capital +2 11 to 50 2014
Claris Biotherapeutics Claris Biotherapeutics develops biologic therapies for corneal diseases and ocular surface disorders. Biotech Jersey City Series B $118.0M 2026-07-28 $225.1M RA Capital Management, Novo Holdings, Janus Henderson Investors +1 1 to 10 2018
Bunkerhill Health Bunkerhill Health develops AI agents that enhance clinical and operational teams within health systems. Artificial intelligence Palo Alto Series B $25.0M 2026-07-16 $55.0M Y Combinator, SciFi VC, Pacific 8 Ventures 11 to 50 2022
Kuehnle Agrosystems Kuehnle Agrosystems develops plant-based systems to produce biologically active compounds through biotech research. Biotech Honolulu Series B $3.0M 2026-07-06 $11.8M S2G Investments, Cavallo Ventures, Aqua Spark +2 1 to 10 2007
Materna Medical Materna Medical develops medical devices that help women protect and restore their pelvic health. Health care Mountain View Series B $5.0M 2026-07-01 $62.6M Golden Seeds, Band of Angels, Wavemaker 360 +2 11 to 50 2010
xCures xCures aggregates, organizes, and structures electronic medical records across multiple diseases and data types. Artificial intelligence Oakland Series B $46.0M 2026-06-24 $59.0M Metaplanet, Wavemaker 360, Portfolia +2 11 to 50 2018
Cour Pharmaceuticals Development Cour Pharmaceuticals Development develops nanoparticle technology to reset immune systems in multiple sclerosis patients. Biotech Skokie Series B $50.0M 2026-06-18 $185.5M Alpha Wave Global, Bristol-Myers Squibb, Alpha Wave Ventures +2 51 to 100 2015
California Naturals California Naturals sells clean, safe, natural personal care goods at affordable prices. Health care Los Angeles Series B $21.0M 2026-06-03 $25.0M L Catterton, Elizabeth Street Ventures, Midnight Venture Partners +2 1 to 10 2023
Triomics Triomics matches patients to clinical trials using generative AI technology. Artificial intelligence San Francisco Series B $22.0M 2026-05-27 $37.1M Y Combinator, Lightspeed Venture Partners, General Catalyst +2 51 to 100 2021
9amHealth 9amHealth offers a simplified approach to whole body health, including weight loss and diabetes management. Health care Encinitas Series B $26.0M 2026-05-12 $55.2M Founders Fund, Speedinvest, StartUp Health +2 251 to 500 2021
LTZ Therapeutics LTZ Therapeutics develops novel immunotherapies for cancer and other diseases with unmet clinical needs. Biotech San Francisco Series B $38.0M 2026-05-06 $125.0M Qiming Venture Partners, Shunwei Capital, K2VC +1 11 to 50 2022
Courier Health Courier Health develops a patient relationship management platform for life sciences and biopharma companies. Health care New York Series B $50.0M 2026-04-22 $70.5M Norwest, Work-Bench 101 to 250 2021
Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Cambridge Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017

Table 1. Health care startups that raised Series B in the United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 1,286.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 David David makes high-protein, low-calorie foods that support muscle growth and fat reduction. Health care New York Series B $250.0M 2026-09-02 $335.0M Valor Siren Ventures 101 to 250 2023
2 Mirador Therapeutics Mirador Therapeutics develops precision medicines for immune-mediated diseases. Biotech San Diego Series B $250.0M 2026-01-12 $730.0M OrbiMed, Fidelity, ARCH Venture Partners +1 11 to 50 2024
3 Qualified Health Qualified Health develops AI tools that support clinical decisions and patient care management. Artificial intelligence San Carlos Series B $125.0M 2026-03-25 $155.0M SignalFire, Flare Capital Partners, Town Hall Ventures +1 51 to 100 2023
4 Diagonal Therapeutics Diagonal Therapeutics develops targeted therapies for cancer and genetic diseases. Biotech Watertown Series B $125.0M 2026-01-08 $253.0M Lightspeed Venture Partners, RA Capital Management, Atlas Venture +1 11 to 50 2022
5 Claris Biotherapeutics Claris Biotherapeutics develops biologic therapies for corneal diseases and ocular surface disorders. Biotech Jersey City Series B $118.0M 2026-07-28 $225.1M RA Capital Management, Novo Holdings, Janus Henderson Investors +1 1 to 10 2018
6 Sanegene Bio Sanegene Bio develops an RNAi drug discovery platform aimed at unmet clinical needs. Biotech Woburn Series B $110.0M 2025-12-08 $240.0M Shenzhen Capital Group, Qiming Venture Partners, Northern Light Venture Capital +1 51 to 100 2021
7 Aureka Biotechnologies Aureka Biotechnologies uses AI to discover protein therapeutics and antibody treatments. Artificial intelligence Laguna Hills Series B $100.0M 2026-08-10 $168.4M K2VC, NRL Capital 11 to 50 2023
8 Ambrosia Biosciences Ambrosia Biosciences provides drug development services for small molecule therapies targeting obesity and metabolic disorders. Biotech Boulder Series B $100.0M 2026-03-31 $141.0M Boulder Ventures, Biotechnology Value Fund 11 to 50 2024
9 BlossomHill Therapeutics BlossomHill Therapeutics is a biopharmaceutical company focused on oncology and autoimmune disorders. Biotech San Diego Series B $84.0M 2025-12-10 $257.0M OrbiMed, Cormorant Asset Management, Vivo Capital +2 11 to 50 2020
10 Apella Technology Apella Technology is an AI company that applies modern engineering to improve surgical procedures. Artificial intelligence Oakland Series B $80.0M 2026-01-07 $104.0M Operator Partners, Upside Partnership, Casdin Capital +1 51 to 100 2019

Table 2. Health care startups that raised Series B in the United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Alumni Ventures Angel group Manchester, United States 16 1% 2 Benepass, Sorcero
2 General Catalyst Venture capital firm San Francisco, United States 13 1% 4 Evvy, Faro AI, Triomics
3 RA Capital Management Startup incubator Boston, United States 13 1% 3 Superluminal Medicines, Claris Biotherapeutics, Diagonal Therapeutics
4 Y Combinator Startup accelerator Mountain View, United States 12 1% 6 Multiply Labs, Arintra, Bunkerhill Health
5 National Science Foundation Entrepreneurship program Alexandria, United States 12 1% 4 Vibronix, Kytopen, BreezeBio
6 OrbiMed Private equity firm New York, United States 11 1% 2 Mirador Therapeutics, BlossomHill Therapeutics
7 Andreessen Horowitz Venture capital firm Menlo Park, United States 11 1%
8 Google Ventures Corporate venture arm San Francisco, United States 10 1% 1 Moonwalk Biosciences
9 F-Prime Venture capital firm Cambridge, United States 9 1% 1 Nocion Therapeutics
10 8VC Venture capital firm Austin, United States 9 1% 1 Ritten
11 ARCH Venture Partners Venture capital firm Chicago, United States 8 1% 2 Moonwalk Biosciences, Mirador Therapeutics
12 Alexandria Venture Investments Venture capital firm Pasadena, United States 8 1% 1 Kytopen
13 Founders Fund Venture capital firm San Francisco, United States 7 1% 2 Multiply Labs, 9amHealth
14 Bristol-Myers Squibb Venture capital firm New York, United States 7 1% 2 Cour Pharmaceuticals Development, Precede Biosciences
15 Flare Capital Partners Venture capital firm Boston, United States 7 1% 1 Qualified Health

Table 3. Health care startups that raised Series B in the United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 609 47% $47.7B
Software 289 22% $13.7B
Artificial intelligence 110 9% $8.0B
Hardware 62 5% $2.0B
Fintech 45 3% $2.3B
Commerce 37 3% $1.3B
Education 13 1% $555.1M
Cybersecurity 6 0% $195.3M

Table 4. Health care startups that raised Series B in the United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 1,286 100% $23.0M

Table 5. Health care startups that raised Series B in the United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
San Francisco 88 7%
New York 87 7%
Cambridge 75 6%
Boston 61 5%
San Diego 60 5%
Seattle 34 3%
Palo Alto 25 2%
Los Angeles 22 2%
Austin 20 2%
Houston 20 2%
Waltham 16 1%
San Jose 16 1%

Table 6. Health care startups that raised Series B in the United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 1% $41.9M
October 2026 8 6% $685.8M
September 2026 13 10% $822.9M
August 2026 14 10% $700.6M
July 2026 12 9% $414.4M
June 2026 16 12% $1.3B
May 2026 5 4% $234.5M
April 2026 8 6% $384.1M
March 2026 9 7% $545.5M
February 2026 7 5% $334.0M
January 2026 20 15% $1.1B
December 2025 17 13% $833.8M
November 2025 4 3% $274.7M

Table 7. Health care startups that raised Series B in the United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 113 9% $6.5B
2025 139 11% $6.8B
2024 117 9% $5.2B
2023 101 8% $3.9B
2022 104 8% $3.5B
2021 141 11% $6.4B

Table 8. Health care startups that raised Series B in the United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 30 2%
2020 to 2022 156 12%
2015 to 2019 456 36%
2010 to 2014 294 23%
Before 2010 345 27%

Table 9. Health care startups that raised Series B in the United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 224 18%
11 to 50 593 47%
51 to 100 228 18%
101 to 250 136 11%
251 to 500 43 3%
501 to 1,000 22 2%
1,001 to 5,000 11 1%
5,001 to 10,000 2 0%
10,001 or more 8 1%

Table 10. Health care startups that raised Series B in the United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in the United States whose last round is Series B are on the list?
1,286, in the file dated 16 November 2026. 134 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 1,286 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series B in the United States: 1,286 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in United States

Other sectors that raised Series B in United States

Cite: FundingWatcher, 1,286 health care companies in the United States whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-b/united-states/